Sensato Investors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-584,274
Closed -$15.8M 110
2015
Q4
$15.8M Buy
584,274
+101,240
+21% +$2.61M 2.98% 11
2015
Q3
$10.6M Buy
483,034
+13,939
+3% +$356K 1.98% 20
2015
Q2
$13.4M Sell
469,095
-446,580
-49% -$13M 2.8% 15
2015
Q1
$25M Buy
915,675
+755,574
+472% +$20.8M 5.4% 2
2014
Q4
$4.23M Buy
+160,101
New +$4.69M 1.25% 23

Other funds holding MR

Sensato Investors's MR Position: Q1 2016 in Review

Sensato Investors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 584,274 shares — an estimated $15.8M sold.

Sensato Investors first reported a position in MR in Q4 2014 and held it in 5 quarters. The position peaked at $25M in Q1 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Sensato Investors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Sensato Investors sold 584,274 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $15.8M.
  • Sensato Investors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2014 and held it in 5 quarters.
  • Sensato Investors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $25M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Sensato Investors's 13F filing for Q1 2016, filed 16 May 2016.